A. Kirchner et al., Upregulation of matrix metalloproteinase-9 in the cerebrospinal fluid of patients with acute Lyme neuroborreliosis, J NE NE PSY, 68(3), 2000, pp. 368-371
It was investigated (1) whether metalloproteinase-9 (MMP-9), MMP-3, and tis
sue inhibitor of matrix metalloproteinase-1 (TIMP-1, the natural tissue inh
ibitor of MMP-9) are increased in the CSF of patients with Lyme neuroborrel
iosis and (2) whether macrophages can express MMP-9 when stimulated with Bo
rrelia burgdorferi. Zymography showed MMP-9 activity in 26 of 31 (84%) CSF
samples from patients with acute stage 2 Lyme neuroborreliosis, but not in
20 controls with non-inflammatory neurological disorders. Activity of MMP-2
was detected in all CSF samples in both patients with neuroborreliosis and
controls, suggesting a constitutive release of MMP-2. Using enzyme linked
immunosorbent assay (ELISA) MMP-3 (which can activate MMP-9) was detected i
n low concentrations in the CSF of 13 of 29 patients with neuroborreliosis,
but not in controls. TIMP-1 was increased twofold in CSF samples from pati
ents with neuroborreliosis in comparison with the controls. MMP-9 activity
was induced in vitro in a mouse macrophage cell Line (RAW 264.7) when stimu
lated with two different genospecies of B burgdorferi (B garinii, B afzelii
). This MMP-9 activity was reduced in a dose dependent manner when macropha
ges stimulated with B burgdorferi were coincubated with NF-kappa B SN50, a
cell assay activate permeable peptide which inhibits the translocation of N
F-kappa B into the nucleus of stimulated cells. The data show that (1) MMP-
9 activity is present in the CSF of patients with neuroborreliosis, (2) mac
rophages stimulated with B burgdorferi are a possible source of MMP-9 incre
ase, and (3) activation of NF-kappa B may play a part in the upregulation o
f MMP-9 by B burgdorferi.